Monthly editorial theme | An introduction to the use of transplantation for the treatment of AML
Sylvia Agathou , Nov 11, 2019
Impact of donor type on outcomes of allogeneic transplant
Emily Smith , Nov 1, 2019
ESH 2019 | What are the new concepts to target cancer stem cells in AML?
Ravi Majeti , Nov 1, 2019
ESH 2019 | How do you integrate molecular diagnostics in clinical practice?
Peter Valk , Nov 1, 2019
ESH 2019 | Is there a need to change AML risk stratification?
Eytan Stein , Nov 1, 2019
ESH 2019 | Why should we target RUNX1 in AML treatment?
Guy Sauvageau , Nov 1, 2019